Outlook Therapeutics's total assets for Q3 2024 were $47.09M, a decrease of -20.22% from the previous quarter. OTLK total liabilities were $130.77M for the fiscal quarter, a -32.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.